MONISTAT 1 COMBINATION PACK Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Monistat 1 Combination Pack, and when can generic versions of Monistat 1 Combination Pack launch?
Monistat 1 Combination Pack is a drug marketed by Medtech Products and is included in one NDA.
The generic ingredient in MONISTAT 1 COMBINATION PACK is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Monistat 1 Combination Pack
A generic version of MONISTAT 1 COMBINATION PACK was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MONISTAT 1 COMBINATION PACK?
- What are the global sales for MONISTAT 1 COMBINATION PACK?
- What is Average Wholesale Price for MONISTAT 1 COMBINATION PACK?
Summary for MONISTAT 1 COMBINATION PACK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 114 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,906 |
| What excipients (inactive ingredients) are in MONISTAT 1 COMBINATION PACK? | MONISTAT 1 COMBINATION PACK excipients list |
| DailyMed Link: | MONISTAT 1 COMBINATION PACK at DailyMed |
Recent Clinical Trials for MONISTAT 1 COMBINATION PACK
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Central "Dr. Ignacio Morones Prieto" | Phase 4 |
| Universidad Autonoma de San Luis Potosà | Phase 4 |
US Patents and Regulatory Information for MONISTAT 1 COMBINATION PACK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medtech Products | MONISTAT 1 COMBINATION PACK | miconazole nitrate | CREAM, INSERT;TOPICAL, VAGINAL | 021308-001 | Jun 29, 2001 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MONISTAT 1 COMBINATION PACK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Medtech Products | MONISTAT 1 COMBINATION PACK | miconazole nitrate | CREAM, INSERT;TOPICAL, VAGINAL | 021308-001 | Jun 29, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Medtech Products | MONISTAT 1 COMBINATION PACK | miconazole nitrate | CREAM, INSERT;TOPICAL, VAGINAL | 021308-001 | Jun 29, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MONISTAT 1 COMBINATION PACK
See the table below for patents covering MONISTAT 1 COMBINATION PACK around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Korea | 100701490 | ⤷ Sign Up | |
| World Intellectual Property Organization (WIPO) | 0030626 | ⤷ Sign Up | |
| Argentina | 021863 | METODOS Y EQUIPOS PARA EL TRATAMIENTO DE CANDIDIASIS VULVOVAGINAL, CON NITRATO DE MICONAZOL | ⤷ Sign Up |
| Germany | 69930725 | ⤷ Sign Up | |
| European Patent Office | 1051162 | TECHNIQUES ET KITS DE TRAITEMENT DE LA CANDIDOSE VULVO-VAGINALE A BASE DE NITRATE DE MICONAZOLE (METHODS AND KITS FOR TREATING VULVOVAGINAL CANDIDIASIS WITH MICONAZOLE NITRATE) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
